Telmisartan Tablets

The Defense Logistics Agency Troop Support Medical Supply Chain is seeking a requirements contract for Telmisartan tablets in three strengths (20mg, 40mg, and 80mg) packaged in 30-count bottles. The solicitation (SPE2D2-24-R-0015) is structured as a one-year base contract with four one-year option periods, designed to supply pharmaceutical products through the DLA and VA Pharmaceutical Prime Vendor (PPV) programs for Department of Defense, Veterans Affairs, Indian Health Service, and Bureau of Prisons facilities. Key contract requirements include establishing business-to-business agreements with PPV contractors within 15 days of award, being ready to fill orders within 45 days, and meeting specific product specifications such as bar code labeling at the unit-of-use package level, child-proof closures, and automated dispensing unit compatibility. The solicitation requires product registration with multiple pharmaceutical databases including RXNorm, First Data Bank, Multum, and Medi-Span. The original proposal deadline was January 8, 2025, but has been extended to February 28, 2025, at 3:00 PM EST, with a contract price effective date no more than 60 days after award and no sooner than April 6, 2025.

The solicitation does not have a specific set-aside designation and is open to pharmaceutical manufacturers and suppliers. Estimated annual quantities are substantial: 226,592 bottles of 20mg, 372,357 bottles of 40mg, and 396,425 bottles of 80mg tablets. Contractors must be capable of delivering complete order quantities to PPV contractors within 15 calendar days after receiving an order. The solicitation falls under NAICS category 325412 (Pharmaceutical Preparation Manufacturing) and PSC category 6505 (Drugs and Biologicals), indicating the specific industry and product type. While the exact award value is not specified, the volume of tablets suggests a significant potential contract value. The place of performance will be through the DLA and VA Pharmaceutical Prime Vendor program, effectively serving medical facilities across multiple federal agencies. Contractors must also comply with new sustainable product requirements under clause 52.223-23, which references various statutes related to sustainable procurement.